Journal of the American Academy of Dermatology
Volume 57, Issue 6 , Pages 1090-1091 , December 2007

Efalizumab for the treatment of refractory hidradenitis suppurativa

References 

  1. Joseph MA, Jayaseelan E, Ganapathi B, Stephen J. Hidradenitis suppurativa treated with finasteride. J Dermatol Treat. 2005;16:75–78
  2. Rosi YL, Lowe L, Kang S. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease. J Dermatol Treat. 2005;16:58–61
  3. Cusack C, Buckley C. Etanercept: effective in the management of hidradenitis suppurativa. Br J Dermatol. 2006;154:726–729
  4. Moul DK, Korman NJ. Severe hidradenitis suppurativa treated with adalimumab. Arch Dermatol. 2006;142:1110–1112
  5. Gold M, Bridges TM, Bradshaw VL, Boring M. ALA-PDT and blue light therapy for hidradenitis suppurativa. J Drugs Dermatol. 2004;3(1 Suppl):S32–S35

 Genentech Inc provided the medication efalizumab and partially funded the study.

 Disclosure: Dr Strober has acted as a speaker, advisor, consultant, and/or investigator for Abbott, Amgen, Astellas, Genentech, Centocor, Novo Nordisk, and Wyeth. Drs Kim and Siu have no conflicts of interest to declare.

 Reprints not available from the author.

PII: S0190-9622(07)01180-2

doi: 10.1016/j.jaad.2007.07.032

Journal of the American Academy of Dermatology
Volume 57, Issue 6 , Pages 1090-1091 , December 2007

Article Tools